JP Morgan Chase’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-94
Closed -$2.99K 7846
2026
Q1
$2.99K Sell
94
-7,900
-99% -$293K ﹤0.01% 6955
2025
Q4
$278K Sell
7,994
-4,811
-38% -$177K ﹤0.01% 5354
2025
Q3
$478K Buy
+12,805
New +$443K ﹤0.01% 5063
2023
Q3
Sell
-4,000
Closed -$102K 7542
2023
Q2
$102K Buy
4,000
+3,437
+610% +$81.4K ﹤0.01% 5446
2023
Q1
$13K Buy
+563
New +$12.9K ﹤0.01% 6067
2022
Q4
Sell
-563
Closed -$14K 6678
2022
Q3
$14K Buy
563
+100
+22% +$2.77K ﹤0.01% 5892
2022
Q2
$12K Buy
+463
New +$14.9K ﹤0.01% 6001
2021
Q4
Sell
-210
Closed -$10K 6741
2021
Q3
$10K Sell
210
-3,790
-95% -$177K ﹤0.01% 6165
2021
Q2
$185K Buy
4,000
+3,000
+300% +$136K ﹤0.01% 5285
2021
Q1
$44K Sell
1,000
-2,942
-75% -$134K ﹤0.01% 5563
2020
Q4
$162K Hold
3,942
﹤0.01% 4876
2020
Q3
$146K Buy
+3,942
New +$145K ﹤0.01% 4518
2019
Q3
Sell
-20,421
Closed -$695K 5798
2019
Q2
$695K Sell
20,421
-24,084
-54% -$812K ﹤0.01% 4062
2019
Q1
$1.49M Buy
44,505
+44,170
+13,185% +$1.39M ﹤0.01% 3535
2018
Q4
$9K Sell
335
-5,644
-94% -$175K ﹤0.01% 5450
2018
Q3
$230K Buy
5,979
+995
+20% +$36.6K ﹤0.01% 4633
2018
Q2
$175K Hold
4,984
﹤0.01% 4612
2018
Q1
$166K Hold
4,984
﹤0.01% 4432
2017
Q4
$165K Buy
+4,984
New +$166K ﹤0.01% 4490

Other funds holding FFTY

JP Morgan Chase's FFTY Position: Q2 2026 in Review

JP Morgan Chase sold out of CapForce IBD 50 ETF (FFTY) in Q2 2026, closing a stake of 94 shares — an estimated $2.99K sold.

JP Morgan Chase first reported a position in FFTY in Q4 2017 and held it in 19 quarters. The position peaked at $1.49M in Q1 2019. 33 funds tracked by Wall St. Rank hold FFTY as of Q2 2026.

  • JP Morgan Chase reported no remaining CapForce IBD 50 ETF position as of Q2 2026 after selling out during the quarter.
  • JP Morgan Chase sold 94 CapForce IBD 50 ETF shares in Q2 2026, an estimated $2.99K.
  • JP Morgan Chase first reported a position in CapForce IBD 50 ETF in Q4 2017 and held it in 19 quarters.
  • JP Morgan Chase's CapForce IBD 50 ETF position peaked at $1.49M in Q1 2019.
  • 33 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.